Bipartisan Federal Proposal Seeks to Update Hemp-Derived CBD Rules

July 27, 2023 · Ganjapreneur

A group of federal lawmakers last week introduced bipartisan, bicameral legislation aimed at updating federal hemp rules to ensure hemp-derived CBD products are regulated by the U.S. Food and Drug Administration (FDA) like other legal products used in dietary supplements, foods, and beverages.  

In a press release, the lawmakers – Senators Ron Wyden (D-OR), Rand Paul (R-KY), and Jeff Merkley (D-OR) and Rep. Earl Blumenauer (D-OR) – said the Hemp Access and Consumer Safety Act “is essential to protecting consumer safety and treating hemp producers fairly.” 

The legislation would give hemp-derived CBD products an opportunity to lawfully be used in dietary supplements, foods, and beverages under the federal Food, Drug and Cosmetic Act; prioritize consumer safety, requiring manufacturers to comply with all existing federal regulations for the products that contain CBD; and ensure that these products are properly labeled. 

The lawmakers noted that the Food, Drug, and Cosmetics Act prohibits any new dietary ingredient, food, or beverage from entering the market if it hasn’t been studied or approved as a drug. The FDA has the authority to exempt items from this prohibition, but has yet to exempt hemp-derived CBD, despite congressional action to legalize its production and sale. By exempting hemp-derived CBD from the prohibition, the FDA would be permitted to regulate hemp-derived CBD like all other new dietary ingredients, foods, and beverages. 

In a statement, Jonathan Miller, general counsel of the U.S. Hemp Roundtable, said the measure “provides a much needed pathway for FDA to establish a clear and consistent framework for the production, marketing, and sale of hemp-derived CBD to ensure consumer safety while fostering a thriving, regulated market.”  

In January the FDA announced that that it does not plan to issue implementing regulations following the legalization of hemp in the 2018 Farm Bill. Instead, the agency said it would “work with Congress” on a regulatory pathway for CBD.  (Full Story)

In categories:CBD Politics
Next Post

Congressional Committee Addresses FDA Inaction On CBD Regulations At Hearing

A first-of-its-kind congressional committee hearing took place on Thursday, with lawmakers examining the impacts of Food and Drug Administration (FDA) inaction on developing regulations to allow for the sale of hemp-derived CBD as food items or dietary supplements. The House…
Read
Previous Post

House Approves Veterans Medical Marijuana Access And Psychedelics Research Amendments As Part Of Spending Bill

The U.S. House of Representatives has approved amendments to a large-scale spending bill that would allow U.S. Department of Veterans Affairs (VA) doctors to recommend medical cannabis to military veterans and promote research into substances like psilocybin and MDMA. Just…
Read
Random Post

Columbia Care Changes Name to The Cannabist Company

Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) is changing its legal name to The Cannabist Company Holdings Inc. as it aligns more closely with its retail store name. The company is rebranding to The Cannabist Company and is also changing its trading symbols on the CBOE Canada…
Read
Random Post

Federal Health Agency Awards $3.2 Million Grant To Study Impact Of Marijuana On Cancer Immunotherapy Treatment

The federal health agency is awarding researchers $3.2 million to study the effects of using cannabis while receiving immunotherapy for cancer treatment, as well as whether access to marijuana helps reduce health disparities. The University of Buffalo (UB) announced that…
Read
Random Post

Texas University Awarded USDA Grant to Study Hemp as Animal Feed

Agricultural scientists at Texas’ Prairie View A&M University (PVAMU) have received a $299,162 grant from the United States Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) to study the use of hemp as animal feed.    The three-year study…
Read
Random Post

New Jersey Dispensary Count Nearly Triples in 2023

New Jersey added fifty-seven licensed, operational dispensaries in 2023, the first full year of adult-use legalization in the state. When adult-use legislation went into effect in April 2022, only twenty-two recreational dispensaries existed to serve the state’s twenty-one counties and…
Read